title: Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy.
abstract: An association of hidradenitis suppurativa with Crohn's disease is supported by previous repent. We here report a patient with hidradenitis suppurativa who subsequently developed peripheral arthritis, sacroiliitis, and Crohn's disease. A significant attenuation of bowel, cutaneous, and joint symptoms was achieved after treatment with monoclonal antibody against tumor necrosis factor (TNF). The pathogenetic aspects according to the literature and response to the various therapeutic measures applied are also presented.
authors: Department of Gastroenterology, University Hospital of Heraklion, University General Hospital, PO Box 1352, 71110, Crete, Heraklion, Greece.
authors: Maria
authors: M
authors: Roussomoustakaki
authors: Philippos
authors: P
authors: Dimoulios
authors: Constantinos
authors: C
authors: Chatzicostas
authors: Heraklis D
authors: HD
authors: Kritikos
authors: John
authors: J
authors: Romanos
authors: John G
authors: JG
authors: Panayiotides
authors: Elias A
authors: EA
authors: Kouroumalis
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001365:Axilla / Q000473:pathology; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D017497:Hidradenitis Suppurativa / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D012446:Sacroiliac Joint / Q000473:pathology*; D025242:Spondylarthropathies / Q000188:drug therapy / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D001379:Azathioprine